Failure of gastric inhibitory polypeptide to inhibit pentagastrin-stimulated acid secretion in vagotomized human subjects
- 1 October 1981
- journal article
- research article
- Published by Springer Nature in Digestive Diseases and Sciences
- Vol. 26 (10) , 902-904
- https://doi.org/10.1007/bf01309494
Abstract
Five vagotomized male subjects were given graded doses of pentagastrin without and with a background infusion of 2 μg/kg/hr of gastric inhibitory polypeptide (GIP). An insulin infusion test (0.1 units/kg/hr) showed that the vagotomies were complete. GIP infusion failed to inhibit pentagastrin-stimulated acid and pepsin secretion even though plasma GIP concentration reached a plateau much higher than that measured after ingestion of a meal. We conclude that GIP does not inhibit pentagastrin-stimulated gastric acid secretion in vagotomized human subjects.This publication has 6 references indexed in Scilit:
- Effect of gastric inhibitory polypeptide on pentagastrin-stimulated acid secretion in manDigestive Diseases and Sciences, 1980
- Effect of Continuous Intravenous Infusion of Insulin Versus Rapid Intravenous Injection of Insulin on Gastric Acid Secretion in ManGastroenterology, 1975
- Further purification of a polypeptide demonstrating enterogastrone activityThe Journal of Physiology, 1970
- A Modified Hemoglobin Substrate Method for the Estimation of Pepsin in Gastric JuiceScandinavian Journal of Gastroenterology, 1970